ExoLuminate Study for Early Detection of Pancreatic Cancer

Plain-language summary

This is an observational study that evaluates a blood test for the early detection of pancreatic cancer. People aged 18 and older who meet the criteria for one of the study cohorts and can provide a blood sample may take part. It is a non-interventional (observational) study and is currently recruiting.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Biological Dynamics

Start date

12/19/2022

Estimated completion

1/1/2028

Countries

United States

Related genes

Locations

• San Diego, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* ≥18 years old.
* Meeting criteria for one of the study cohorts.
* Capable of giving informed consent.
* Able to provide a blood sample.

Exclusion Criteria:

* \< 18 years old.
* Pregnancy.
* Active cancer (other than pancreatic cancer) and/or undergoing treatment for an active cancer diagnosis (except for skin malignancies).
* Prior organ transplant or bone marrow transplant.
* History of fainting or other adverse effects when blood is drawn.
* Any condition that, in the opinion of the investigator, should preclude enrollment.